IPO
Akston Biosciences Corp
Filed with the SEC to go public on Oct 8, 2025. Newest amendment May 4, 2026.
Terms
| Price range | US$8.00 to US$10.00 a share | |
| Shares offered | 2,222,222 shares of common stock | |
| Offering size | US$17.8 million to US$22.2 million | Shares offered times the price range, worked out by 6ix |
| Underwriters' option | Up to 333,333 more shares | |
| Listing | AXTN on NYSE American | Has applied to list |
| Underwriter | ThinkEquity |
From the cover of the amended prospectus (S-1/A) filed May 4, 2026
Steps
| Draft sent to the SEC in confidence | Jul 25, 2025 |
| Filed publicly | Oct 8, 2025 |
| Amended 6 times | Newest May 4, 2026 |
| Shares registered with an exchange | Not yet |
| Declared effective by the SEC | Not yet |
| Final prospectus, with the price | Not yet |
Filings
- May 4, 2026 FWP · Free writing prospectus
- May 4, 2026 S-1/A · Registration statement, amended
- Apr 10, 2026 FWP · Free writing prospectus
- Apr 10, 2026 S-1/A · Registration statement, amended
- Feb 18, 2026 FWP · Free writing prospectus
- Feb 18, 2026 S-1/A · Registration statement, amended
- Jan 15, 2026 FWP · Free writing prospectus
- Jan 15, 2026 S-1/A · Registration statement, amended
- Dec 8, 2025 S-1/A · Registration statement, amended
- Nov 17, 2025 S-1/A · Registration statement, amended
- Oct 8, 2025 S-1 · Registration statement
- Sep 19, 2025 DRS/A · Draft registration statement, amended
- Jul 25, 2025 DRS · Draft registration statement